CNBC August 29, 2023
Key Points
– The Biden administration unveiled the first 10 prescription drugs that will be subject to price negotiations between manufacturers and Medicare.
– The announcement kicks off a controversial process under the Inflation Reduction Act that aims to make costly medications more affordable for older Americans.
– The list includes Bristol-Myers Squibb’s blood thinner Eliquis, Johnson & Johnson’s own blood thinner, Novo Nordisk insulin products and Merck’s diabetes drug Januvia.
The Biden administration on Tuesday unveiled the first 10 prescription drugs that will be subject to price negotiations between manufacturers and Medicare, kicking off a controversial process that aims to make costly medications more affordable for older Americans.
President Joe Biden’s Inflation Reduction Act, which passed in...
Today's Sponsors
Today's Sponsor